| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| REED JOHN C | EVP, Innovative Medicine, R&D | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK | /s/ Laura H. McFalls, as attorney-in-fact for John C. Reed | 20 Oct 2025 | 0001181561 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JNJ | Common Stock | Options Exercise | $3,430,180 | +21,721 | +204% | $157.92 | 32,379 | 17 Oct 2025 | Direct | |
| transaction | JNJ | Common Stock | Sale | $4,185,793 | -21,721 | -67% | $192.71 | 10,658 | 17 Oct 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JNJ | Employee Stock Options (Right to Buy) | Options Exercise | $3,430,180 | -21,721 | -33% | $157.92 | 43,442 | 17 Oct 2025 | Common Stock | 21,721 | $157.92 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $192.69 to $192.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. |